Technical Analysis for TSHA - Taysha Gene Therapies, Inc.

Grade Last Price % Change Price Change
C 27.81 -0.93% -0.26
TSHA closed up 5.29 percent on Wednesday, February 24, 2021, on 32 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Down
Historical TSHA trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish -0.93%
Crossed Above 50 DMA Bullish -0.93%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.93%
Inside Day Range Contraction -0.93%
Fell Below 50 DMA Bearish 4.31%
Fell Below 20 DMA Bearish -4.43%
Multiple of Ten Bearish Other -4.43%
Inside Day Range Contraction -4.43%
Crossed Above 20 DMA Bullish -9.53%
Pocket Pivot Bullish Swing Setup -9.53%
Older End-of-Day Signals for TSHA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
50 DMA Support about 2 hours ago
Down 3% about 3 hours ago
Outside Day about 4 hours ago
Down 2 % about 4 hours ago
Fell Below Previous Day's Low about 4 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Taysha Gene Therapies, Inc., a gene therapy company, develops adeno-associated virus based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-101 for the treatment of GM2 gangliosidosis; TSHA-118 for the treatment of CLN1 disease; TSHA-102 for the treatment of Rett syndrome; TSHA-103 for the treatment of SLC6A1 haploinsufficiency disorder; and TSHA-104 for the treatment for Surfeit locus 1 deficiency. The company also has strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments. Taysha Gene Therapies, Inc. was founded in 2019 and is based in Dallas, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Rare Diseases Gene Therapy Lipid Storage Disorders Monogenic University Of Texas Deficiency Gangliosidosis Gm2 Gangliosidoses Gm2 Gangliosidosis Monogenic Diseases

Is TSHA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 33.35
52 Week Low 18.16
Average Volume 122,838
200-Day Moving Average 0.00
50-Day Moving Average 27.62
20-Day Moving Average 29.11
10-Day Moving Average 29.13
Average True Range 1.98
ADX 21.78
+DI 19.39
-DI 20.15
Chandelier Exit (Long, 3 ATRs ) 26.45
Chandelier Exit (Short, 3 ATRs ) 31.45
Upper Bollinger Band 32.05
Lower Bollinger Band 26.18
Percent B (%b) 0.32
BandWidth 20.17
MACD Line 0.17
MACD Signal Line 0.57
MACD Histogram -0.3946
Fundamentals Value
Market Cap 1.06 Billion
Num Shares 37.8 Million
EPS
Price-to-Sales 0.00
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.38
Resistance 3 (R3) 30.48 29.81 30.00
Resistance 2 (R2) 29.81 29.22 29.76 29.87
Resistance 1 (R1) 28.94 28.86 29.38 28.84 29.74
Pivot Point 28.27 28.27 28.49 28.22 28.27
Support 1 (S1) 27.40 27.68 27.84 27.30 26.40
Support 2 (S2) 26.73 27.32 26.68 26.27
Support 3 (S3) 25.86 26.73 26.15
Support 4 (S4) 25.76